Abivax
Sign in to saveAbivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
OverviewAI-generated
Abivax is a company based in Paris, France. It is an active organization that was established in 2013.
Synthesized by Vinony from 9 facts across 2 sources: Firecrawl, ROR. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Research organization · ROR
- Type
- Company
- Founded
- 2013
- Location
- Paris, France
- Status
- Active
GRID grid.476046.7
Wikidata facts
- Instance of
- organization
- Official name
- ABIVAX
- Country
- France
- Headquarters
- Paris
- Official website
- abivax.com
Sources (1)
via Wikidata · CC0
~1 min read
Encyclopedic overview
8 sectionsContents
- History
- Products
- Obefazimod in inflammatory diseases
- Obefazimod for the treatment of ulcerative colitis
- Obefazimod for the treatment of Crohn’s disease
- Abivax research activities
- References
- Notes
We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking “Accept,” you agree to our website's cookie use as described in our Cookie Policy. You can change your cookie settings at any time by clicking “Preferences.”
PreferencesDeclineAccept
Excerpted from Wikipedia’s “Abivax” article, available under the CC BY-SA 4.0 licence.